Ceres Pharmaceuticals
The computed 12-month bankruptcy probability of Ceres Pharmaceuticals is 0.3% (very low). The company has been active since 1970 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 55 yrs |
| Board | 3 |
| Locations | 1 |
| Publications | 15 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | volledig | 30-07-2025 | 2025-00345614 |
| 31-12-2023 | volledig | 03-07-2024 | 2024-00215496 |
| 31-12-2022 | volledig | 18-07-2023 | 2023-00257666 |
| 31-12-2021 | volledig | 20-07-2022 | 2022-20224385 |
| 31-12-2020 | volledig | 19-07-2021 | 2021-38100580 |
| 31-12-2019 | volledig | 02-07-2020 | 2020-25600052 |
| 31-12-2018 | volledig | 04-07-2019 | 2019-29000567 |
| 31-12-2017 | volledig | 08-06-2018 | 2018-16800392 |
| 31-12-2016 | volledig | 07-06-2017 | 2017-15200118 |
| 31-12-2015 | volledig | 17-06-2016 | 2016-20300600 |
-
Aquitania BVLegal entityDirector· perm. rep.: Anja ImschootState Gazette act 25011965 (24-01-2025)Current20-12-2024 → present
-
MD CONSULT BVLegal entityDirector· perm. rep.: Mario DebelState Gazette act 25011965 (24-01-2025)Current20-12-2024 → present
-
Current19-05-2023 → present
Historic, not recently confirmed (2)
-
Not recently confirmedlast confirmed in an act from 2017
-
Not recently confirmedlast confirmed in an act from 2017
Former directors (3)
-
Former09-02-2017 → 19-04-2021
5 events
- 19-04-2021 Resigned· Director
- 24-12-2018 Mandate renewed· Director
- 24-12-2018 Appointed· Managing director
- 09-02-2017 Mandate renewed· Director
- 09-02-2017 Appointed· Managing director
-
Former09-02-2017 → 21-11-2019
2 events
- 21-11-2019 Resigned· Director
- 09-02-2017 Mandate renewed· Director
-
Former09-02-2017 → 21-11-2019
2 events
- 21-11-2019 Resigned· Director
- 09-02-2017 Mandate renewed· Director
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| Clybouw Bedrijfsrevisoren BVCurrent Statutory auditor · represented by Arnaud Clybouw |
- | 19-05-2023 → present |
Show 3 earlier auditors
| Achiel Clybouw, André Clybouw & Co bedrijfsrevisoren BVBA Statutory auditor · represented by Amaud Clybouw succeeded by Clybouw Bedrijfsrevisoren BV in 2023 |
- | 21-11-2019 → 19-05-2023 |
| BV ovv BVBA Achiel Clybouw, André Clybouw & C° Bedrijfsrevisoren Statutory auditor · represented by Arnaud Clybouw succeeded by Achiel Clybouw, André Clybouw & Co bedrijfsrevisoren BVBA in 2019 |
- | 09-02-2017 → 21-11-2019 |
| Roger Broos Statutory auditor succeeded by BV ovv BVBA Achiel Clybouw, André Clybouw & C° Bedrijfsrevisoren in 2017 |
- | 02-07-2015 → 09-02-2017 |
| NACE primary | Groothandel in farmaceutische en medische artikelen(46460) |
| Legal form | Public limited company(014) |
| Incorporation | 23-09-1970 |
| Status | Active |
| Postal code | 9051 |
Show 2 more network connections
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44062B0301/00D003 | Flanders | 1.1 ha | 1 · 3,960 m² | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 17 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
10-03-2026 1 director appointed, 1 resigning
- PwC Bedrijfsrevisoren BV, Commissaris
- PwC Bedrijfsrevisoren BV, Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_in",
"role": "commissaris",
"person": null,
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "PwC Bedrijfsrevisoren BV",
"address": "1831 Diegem, Culliganlaan 5",
"country": "BE",
"legal_form": "BV"
},
"statutory": null,
"compensated": true,
"effective_date": null,
"evidence_quote": "De algemene vergadering benoemt PwC Bedrijfsrevisoren BV, met maatschappelijke zetel te 1831 Diegem, Culliganlaan 5, als commissaris voor een termijn van drie jaar.",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": 3
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "commissaris",
"person": null,
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "PwC Bedrijfsrevisoren BV",
"address": "1831 Diegem, Culliganlaan 5",
"country": "BE",
"legal_form": "BV"
},
"statutory": null,
"compensated": true,
"effective_date": null,
"evidence_quote": "Deze vennootschap wijst overeenkomstig artikel 3:60 WVV Wouter Coppens BV, aan, voor de uitoefening van het mandaat, met als vaste vertegenwoordiger Wouter Coppens, bedrijfsrevisor.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "vaste_vertegenwoordiger",
"person": {
"rrn": null,
"name": "Wouter Coppens",
"address": null,
"birth_date": null,
"profession": "bedrijfsrevisor",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Wouter Coppens BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": null,
"compensated": true,
"effective_date": null,
"evidence_quote": "Deze vennootschap wijst overeenkomstig artikel 3:60 WVV Wouter Coppens BV, aan, voor de uitoefening van het mandaat, met als vaste vertegenwoordiger Wouter Coppens, bedrijfsrevisor.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "mandate_termination_de_plein_droit",
"role": "commissaris",
"person": null,
"reason": "de_plein_droit_dissolution",
"subkind": null,
"via_org": {
"kbo": null,
"name": "PwC Bedrijfsrevisoren BV",
"address": "1831 Diegem, Culliganlaan 5",
"country": "BE",
"legal_form": "BV"
},
"statutory": null,
"compensated": true,
"effective_date": null,
"evidence_quote": "Het mandaat vervalt na de algemene vergadering die de jaarrekening per 31 december 2027 dient goed te keuren.",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2027"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Gent",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2026-03-10",
"filing_date": "2026-03-02",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2025-06-11",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0407.326.754",
"name_full": "Ceres Pharmaceuticals",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "Aquitania",
"person_name": null,
"org_rep_person_name": "Anja Imschoot",
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}12-05-2025 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": true,
"seat_change": false,
"object_change": false,
"effective_date": "2025-05-06",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0407.326.754",
"name_full": "KELA PHARMA",
"legal_form": "NV"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}24-01-2025 2 directors appointed
- Anja Imschoot, Bestuurder
- Mario Debel, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Anja Imschoot",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Aquitania BV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-12-20",
"evidence_quote": "De enige aandeelhouder beslist om: - Aquitania BV, vast vertegenwoordigd door mevrouw Anja Imschoot ... te benoemen tot bestuurders van de Vennootschap met ingang van 20 december 2024."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Mario Debel",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "MD Consult BV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-12-20",
"evidence_quote": "De enige aandeelhouder beslist om: ... - MD Consult BV, vast vertegenwoordigd door de heer Mario Debel te benoemen tot bestuurders van de Vennootschap met ingang van 20 december 2024."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0407.326.754",
"name_full": "KELA PHARMA",
"legal_form": "NV"
}
}15-05-2024 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0407.326.754",
"name_full": "KELA PHARMA",
"legal_form": "NV"
}
}12-01-2024 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": null,
"notary": {
"name": "Tom Holvoet",
"firm_city": null,
"firm_name": "Notariaat Holvoet, F\u0026T notarisvennootschap",
"office_city": "Antwerpen",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2024-01-12",
"filing_date": "2024-01-10",
"act_kind_objet": "DOEL, DIVERSEN, ALGEMENE VERGADERING, BENAMING,"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-12-19",
"unanimous": true
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0407.326.754",
"name": "KELA PHARMA",
"role": "contributor",
"address": "Sint Lenaartseweg 48 2320 Hoogstraten",
"is_foreign": false,
"legal_form": "Naamloze vennootschap",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [
"7:154",
"7:212",
"7:213"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": null,
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0407.326.754",
"name_full": "KELA PHARMA",
"legal_form": "Naamloze vennootschap"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tom Holvoet",
"org_rep_person_name": null
},
"summary_narrative": "De vennootschap KELA PHARMA heeft een buitengewone algemene vergadering gehouden om de statuten aan te passen aan de bepalingen van het Wetboek van vennootschappen en verenigingen. De wijzigingen omvatten onder meer de naam (inclusief schrapping van de afkorting KELA), de rechtsvorm, het voorwerp, het kapitaal, het bestuur en de algemene vergadering. Het voorwerp is uitgebreid met activiteiten in Belgi\u00EB en het buitenland, zoals het ontwikkelen en verkopen van chemische en farmaceutische producten, en het beheren van onroerende goederen. De zetel blijft in Hoogstraten, het kapitaal bedraagt \u00E9\u00E9n",
"co_filed_documents": [
"Expeditie van de akte",
"Geco\u00F6rdineerde statuten met een lijst van de oprichtings- en wijzigende akten"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "statutes"
}19-05-2023 1 director appointed, 2 reappointed
- Arnaud Clybouw, Commissaris
- Philemona Van Pelt, Bestuurder
- Renatus Beyers, Bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Philemona Van Pelt",
"address": null,
"birth_date": null
},
"evidence_quote": "Bij eenparigheid van stemmen verlengt de algemene vergadering het mandaat van Mevr. Philemona Van Pelt als bestuurder voor een periode van zes jaar"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Renatus Beyers",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0407326754",
"name": "KELA NV",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Bij eenparigheid van stemmen verlengt de algemene vergadering het mandaat van ... KELA NV vertegenwoordigd door Dhr. Renatus Beyers eveneens voor een periode van zes jaar."
},
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Arnaud Clybouw",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Clybouw Bedrijfsrevisoren BV",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Wordt aangesteld tot commissaris van de vennootschap, BV Clybouw Bedrijfsrevisoren, met zetel te 2610 Antwerpen(Wilrijk), Oosterveldlaan 246. Clybouw Bedrijfsrevisoren BV stelt aan als vaste vertegenwoordiger Arnaud Clybouw, bedrijfsrevisor, bestuurder."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0407.326.754",
"name_full": "KELA PHARMA, AFGEKORT : KELA",
"legal_form": "NV"
}
}08-07-2021 Registered office moved from Sint-Niklaas to Hoogstraten
- Industriepark-West 68, 9100 Sint-Niklaas → Sint Lenaartseweg 48, 2320 Hoogstraten
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Hoogstraten",
"region": null,
"street": "Sint Lenaartseweg",
"country": "BE",
"postcode": "2320",
"box_number": null,
"street_number": "48"
},
"old_address": {
"city": "Sint-Niklaas",
"region": null,
"street": "Industriepark-West",
"country": "BE",
"postcode": "9100",
"box_number": null,
"street_number": "68"
},
"effective_date": null,
"evidence_quote": "Het bestuursorgaar\u0131 stelt voor de maatschappelijke zetel van de vennootschap te verplaatsen naar Sint Lenaartseweg 48, 2320 Hoogstraten. Deze datum zal ingaar\u0131 var\u0131af datum var\u0131 publicatie in het staatsblad."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0407.326.754",
"name_full": "KELA PHARMA, AFGEKORT : KELA",
"legal_form": "NV"
}
}27-04-2021 Beyers René resigns as director
- Beyers René, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Beyers Ren\u00E9",
"address": null,
"birth_date": null
},
"effective_date": "2021-04-19",
"evidence_quote": "De Algemene Vergadering der aandeelhouders gehouden op 29 juni 2020 op de zetel van de vennootschap heeft met eenparigheid van stemmen het ontslag aanvaard van dhr. Renatus Beyers als bestuurder en dit vanaf heden. Er werd kwijting verfeend.",
"discharge_granted": false
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0407.326.754",
"name_full": "KELA PHARMA, AFGEKORT : KELA",
"legal_form": "NV"
}
}21-11-2019 2 resigning, 1 reappointed
- Roberta Sledsens, Bestuurder
- Walter Beyers, Bestuurder
- Amaud Clybouw, Commissaris
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Roberta Sledsens",
"address": null,
"birth_date": null
},
"evidence_quote": "De algemene vergadering gehouden op 14/05/2019, aanvaardt met eenparigheid van stemmen het ontslag van volgende bestuurders: - Mevr. Roberta Sledsens, Schoonzichtlaan 38, 3020 Herent"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Walter Beyers",
"address": null,
"birth_date": null
},
"evidence_quote": "De algemene vergadering gehouden op 14/05/2019, aanvaardt met eenparigheid van stemmen het ontslag van volgende bestuurders: ... Dhr. Walter Beyers, F. Birontstraat 11, 2600 Berchem (Antwerpen)"
},
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Amaud Clybouw",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Achiel Clybouw, Andr\u00E9 Clybouw \u0026 Co bedrijfsrevisoren BVBA",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Met eenparigheid van stemmen beslist de algemene vergadering tot de herbenoeming van de commissaris revisor Achiel Clybouw, Andr\u00E9 Clybouw \u0026 Co bedrijfsrevisoren BVBA (in het kort Clybouw Bedrijfsrevisoren Burg. BVBA), met vaste vertegenwoordiger Amaud Clybouw."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0407.326.754",
"name_full": "KELA PHARMA, AFGEKORT : KELA",
"legal_form": "NV"
}
}24-12-2018 1 director appointed, 1 reappointed
- BEYERS René, Gedelegeerd bestuurder
- BEYERS René, Bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "BEYERS Ren\u00E9",
"address": null,
"birth_date": null
},
"evidence_quote": "De algemene vergadering gehouden op 8 mei 2018 op de maatschappelijke zetel van de vennootschap, heeft \u00E9\u00E9nparig de herbenoeming als bestuurder goedgekeurd van BEYERS Ren\u00E9, White Pane Lane 5670, VTR 4S1 North Vancouver BC, Canada, dit voor een periode van 6 jaar, tot de algemene vergadering te houden"
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "BEYERS Ren\u00E9",
"address": null,
"birth_date": null
},
"evidence_quote": "De vergadering van de Raad van Bestuur, gehouden op 8 mei 2018, op de maatschappelijke zetel van de vennootschap, heeft \u00E9\u00E9nparig de benoeming als gedelegeerd bestuurder goedgekeurd van dhr. BEYERS Ren\u00E9, White Pane Lane 5670, V7R 4S1 North Vancouver BC, Canada, dit tot de jaarvergadering te houden in"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0407.326.754",
"name_full": "KELA PHARMA, AFGEKORT : KELA",
"legal_form": "NV"
}
}14-11-2017 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0407.326.754",
"name_full": "KELA PHARMA, AFGEKORT : KELA",
"legal_form": "NV"
}
}09-02-2017 2 directors appointed, 5 reappointed
- Arnaud Clybouw, Commissaris
- Beyers René, Gedelegeerd bestuurder
- BEYERS Renatus, Bestuurder
- VAN PELT Philomena, Bestuurder
- SLEDSENS Roberta, Bestuurder
- BEYERS René, Bestuurder
- BEYERS Walter, Bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "BEYERS Renatus",
"address": null,
"birth_date": null
},
"evidence_quote": "De algemene vergadering gehouden op 10 mei 2016 op de maatschappelijke zetel van de vennootschap, heeft \u00E9\u00E9nparlg de herbenoeming als bestuurder goedgekeurd van: - BEYERS Renatus, Schijndallei 42, 2900 Schoten"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "VAN PELT Philomena",
"address": null,
"birth_date": null
},
"evidence_quote": "De algemene vergadering gehouden op 10 mei 2016 op de maatschappelijke zetel van de vennootschap, heeft \u00E9\u00E9nparlg de herbenoeming als bestuurder goedgekeurd van: -VAN PELT Philomena, Schijndallei 42, 2900 Schoten"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "SLEDSENS Roberta",
"address": null,
"birth_date": null
},
"evidence_quote": "De algemene vergadering gehouden op 10 mei 2016 op de maatschappelijke zetel van de vennootschap, heeft \u00E9\u00E9nparlg de herbenoeming als bestuurder goedgekeurd van: - SLEDSENS Roberta, Schoonzichtlaan 38, 3020 Winksele"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "BEYERS Ren\u00E9",
"address": null,
"birth_date": null
},
"evidence_quote": "De algemene vergadering gehouden op 10 mei 2016 op de maatschappelijke zetel van de vennootschap, heeft \u00E9\u00E9nparlg de herbenoeming als bestuurder goedgekeurd van: - BEYERS Ren\u00E9, Tennis Crescent 2636 te V6R 2E1 Vancouver, BC Canada,"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "BEYERS Walter",
"address": null,
"birth_date": null
},
"evidence_quote": "De algemene vergadering gehouden op 10 mei 2016 op de maatschappelijke zetel van de vennootschap, heeft \u00E9\u00E9nparlg de herbenoeming als bestuurder goedgekeurd van: - BEYERS Walter, Frans Birontlaan 11, 2600 Berchem,"
},
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Arnaud Clybouw",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "BV ovv BVBA Achiel Clybouw, Andr\u00E9 Clybouw \u0026 C\u00B0 Bedrijfsrevisoren",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Tevens heeft de vergadering beslist om een nieuwe commissaris aan te stellen wegens bereiken van de normale leeftijdsgrens van pensionering van commissaris-revisor dhr. Roger F. Broos en bevestigt \u00E9\u00E9nparig de benoeming tot die functie aan de BV ovv BVBA Achiel Clybouw, Andr\u00E9 Clybouw \u0026 C\u00B0 Bedrijfsrev"
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Beyers Ren\u00E9",
"address": null,
"birth_date": null
},
"evidence_quote": "De vergadering van de Raad van Bestuur, gehouden op 22 november 2016, op de maatschappelijke zetel van de vennootschap, heeft \u00E9\u00E9nparig de benoeming als gedelegeerd bestuurder goedgekeurd van dhr. Beyers Ren\u00E9, White Pane Lane 5670, V7R 4S1 North Vancouver BC Canada"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0407.326.754",
"name_full": "KELA PHARMA, AFGEKORT : KELA",
"legal_form": "NV"
}
}02-07-2015 Roger Broos reappointed as statutory auditor
- Roger Broos, Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Roger Broos",
"address": null,
"birth_date": null
},
"evidence_quote": "De algemene vergadering gehouden op 4 juni 2013 op de maatschappelijke zetel van de vennootschap, heeft \u00E9\u00E9nparig de herbenoeming als commissaris-revisor goedgekeurd van de Heer Roger Broos (IBR 504), Durletstraat 26 te 2018 Antwerpen."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0407.326.754",
"name_full": "KELA PHARMA, AFGEKORT : KELA",
"legal_form": "NV"
}
}08-05-2013 General meeting · Officer appointment · Officer reappointment · Officer resignation
- Publication: 08/05/2013 · Algemene Vereniging van de Geneesmiddelenindustrie
- Filing: 26/04/2013 · Algemene Vereniging van de Geneesmiddelenindustrie
- General meeting: 22/03/2013 · Algemene Vereniging van de Geneesmiddelenindustrie
- Officer appointment: role: lid van de Raad van Bestuur, start_date: 2013-03-22 · AstraZeneca N.V.
- Officer appointment: role: lid van de Raad van Bestuur, start_date: 2013-03-22 · Kela Pharma N.V.
- Officer reappointment: role: lid van de Raad van Bestuur, start_date: 2013-03-22 · Baxter Belgium BVBA
- Officer reappointment: role: lid van de Raad van Bestuur, start_date: 2013-03-22 · MSD Belgium BVBA
- Officer reappointment: role: lid van de Raad van Bestuur, start_date: 2013-03-22 · UCB Pharma N.V.
- Officer resignation: role: lid van de Raad van Bestuur, end_date: 2013-03-22 · Bayer Healthcare N.V.
- Officer resignation: role: lid van de Raad van Bestuur, end_date: 2013-03-22 · Ferring N.V.
Technical details
{
"facts": [
{
"date": "2013-05-08",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 08/05/2013",
"value": "08/05/2013",
"object": null,
"subject": "e1"
},
{
"date": "2013-04-26",
"type": "filing",
"quote": "2 6 APR 2013",
"value": "26/04/2013",
"object": null,
"subject": "e1"
},
{
"date": "2013-03-22",
"type": "general_meeting",
"quote": "ALGEMENE VERGADERING VAN 22 MAART 2013",
"value": "22/03/2013",
"object": null,
"subject": "e1"
},
{
"date": "2013-03-22",
"type": "officer_appointment",
"quote": "Benoeming van: 1. AstraZeneca N.V.",
"value": {
"role": "lid van de Raad van Bestuur",
"start_date": "2013-03-22"
},
"object": "e1",
"subject": "e2",
"_value_raw": {
"role": "lid van de Raad van Bestuur",
"start_date": "22/03/2013"
}
},
{
"date": "2013-03-22",
"type": "officer_appointment",
"quote": "Benoeming van: 2. Kela Pharma N.V.",
"value": {
"role": "lid van de Raad van Bestuur",
"start_date": "2013-03-22"
},
"object": "e1",
"subject": "e3",
"_value_raw": {
"role": "lid van de Raad van Bestuur",
"start_date": "22/03/2013"
}
},
{
"date": "2013-03-22",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 1. Baxter Belgium BVBA",
"value": {
"role": "lid van de Raad van Bestuur",
"start_date": "2013-03-22"
},
"object": "e1",
"subject": "e4",
"_value_raw": {
"role": "lid van de Raad van Bestuur",
"start_date": "22/03/2013"
}
},
{
"date": "2013-03-22",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 2. MSD Belgium BVBA",
"value": {
"role": "lid van de Raad van Bestuur",
"start_date": "2013-03-22"
},
"object": "e1",
"subject": "e5",
"_value_raw": {
"role": "lid van de Raad van Bestuur",
"start_date": "22/03/2013"
}
},
{
"date": "2013-03-22",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 3. UCB Pharma N.V.",
"value": {
"role": "lid van de Raad van Bestuur",
"start_date": "2013-03-22"
},
"object": "e1",
"subject": "e6",
"_value_raw": {
"role": "lid van de Raad van Bestuur",
"start_date": "22/03/2013"
}
},
{
"type": "officer_resignation",
"quote": "Ontslag van: 1. Bayer Healthcare N.V.",
"value": {
"role": "lid van de Raad van Bestuur",
"end_date": "2013-03-22"
},
"object": "e1",
"subject": "e7",
"_value_raw": {
"role": "lid van de Raad van Bestuur",
"end_date": "22/03/2013"
}
},
{
"type": "officer_resignation",
"quote": "Ontslag van: 2. Ferring N.V.",
"value": {
"role": "lid van de Raad van Bestuur",
"end_date": "2013-03-22"
},
"object": "e1",
"subject": "e8",
"_value_raw": {
"role": "lid van de Raad van Bestuur",
"end_date": "22/03/2013"
}
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 1598,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0407.622.902",
"kind": "company",
"name": "Algemene Vereniging van de Geneesmiddelenindustrie",
"attrs": {
"seat": "Terhulpsesteenweg 166, 1170 BRUSSEL",
"legal_form": "Vereniging zonder winstoogmerk",
"short_name": "AVGI"
}
},
{
"id": "e2",
"kbo": "0400.165.679",
"kind": "company",
"name": "AstraZeneca N.V.",
"attrs": {
"seat": "Egide Van Ophemstraat 110, 1180 Brussel"
}
},
{
"id": "e3",
"kbo": "0407.326.754",
"kind": "company",
"name": "Kela Pharma N.V.",
"attrs": {
"seat": "Industriepark West 68, 9100 Sint-Niklaas"
}
},
{
"id": "e4",
"kbo": "0861.155.805",
"kind": "company",
"name": "Baxter Belgium BVBA",
"attrs": {
"seat": "Parc de l\u0027Aliance, Boulevard d\u0027Angleterre 2-4, 1420 Braine-l\u0027Alleud"
}
},
{
"id": "e5",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD Belgium BVBA",
"attrs": {
"seat": "Lynx Binnenhof 5, 1200 Brussel"
}
},
{
"id": "e6",
"kbo": "0403.096.168",
"kind": "company",
"name": "UCB Pharma N.V.",
"attrs": {
"seat": "Researchdreef 60, 1070 Brussel"
}
},
{
"id": "e7",
"kbo": "0400.948.213",
"kind": "company",
"name": "Bayer Healthcare N.V.",
"attrs": {
"seat": "J.E. Mommaertslaan 14, 1831 D\u00EDegem"
}
},
{
"id": "e8",
"kbo": "0428.038.135",
"kind": "company",
"name": "Ferring N.V.",
"attrs": {
"seat": "Capucienenlaan 93C, 9300 Aalst"
}
},
{
"id": "e9",
"kbo": null,
"kind": "person",
"name": "Leo Neels",
"attrs": {
"role": "Algemeen Directeur belast met het dagelijks bestuur"
}
}
]
}08-05-2013 General meeting · Officer appointment · Officer reappointment · Officer resignation
- Publication: 08/05/2013
- Filing: 26/04/2013
- General meeting: 22/03/2013
- Officer appointment: role: Membre du Conseil d'administration, start_date: 2013-03-22 · AstraZeneca S.A.
- Officer appointment: role: Membre du Conseil d'administration, start_date: 2013-03-22 · Kela Pharma S.A.
- Officer reappointment: role: Membre du Conseil d'administration, start_date: 2013-03-22 · Baxter Belgium S.A.
- Officer reappointment: role: Membre du Conseil d'administration, start_date: 2013-03-22 · MSD Belgium SPRL
- Officer reappointment: role: Membre du Conseil d'administration, start_date: 2013-03-22 · UCB Pharma S.A.
- Officer resignation: date: 2013-03-22, role: Membre du Conseil d'administration · Bayer Healthcare S.A.
- Officer resignation: date: 2013-03-22, role: Membre du Conseil d'administration · Ferring S.A.
- Filing representative: role: Directeur général chargé de la gestion journalière · Leo Neels
Technical details
{
"facts": [
{
"date": "2013-05-08",
"type": "publication",
"quote": "Bi s ijlagen bij het Belgisch Staatsblad - 08/05/2013 - Annexes du Moniteur belge",
"value": "08/05/2013",
"object": null,
"subject": null
},
{
"date": "2013-04-26",
"type": "filing",
"quote": "2 6 APR 2013 Greffe",
"value": "26/04/2013",
"object": null,
"subject": null
},
{
"date": "2013-03-22",
"type": "general_meeting",
"quote": "ASSEMBLEE GENERALE DU 22 MARS 2013",
"value": "22/03/2013",
"object": null,
"subject": null
},
{
"date": "2013-03-22",
"type": "officer_appointment",
"quote": "Nomination de: 1. AstraZeneca S.A.",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2013-03-22"
},
"object": null,
"subject": "e1",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "22/03/2013"
}
},
{
"date": "2013-03-22",
"type": "officer_appointment",
"quote": "Nomination de: 2. Kela Pharma S.A.",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2013-03-22"
},
"object": null,
"subject": "e2",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "22/03/2013"
}
},
{
"date": "2013-03-22",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 1. Baxter Belgium S.A.",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2013-03-22"
},
"object": null,
"subject": "e3",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "22/03/2013"
}
},
{
"date": "2013-03-22",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 2. MSD Belgium SPRL",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2013-03-22"
},
"object": null,
"subject": "e4",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "22/03/2013"
}
},
{
"date": "2013-03-22",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 3. UCB Pharma S.A.",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2013-03-22"
},
"object": null,
"subject": "e5",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "22/03/2013"
}
},
{
"date": "2013-03-22",
"type": "officer_resignation",
"quote": "D\u00E9mission de: 1. Bayer Healthcare S.A.",
"value": {
"date": "2013-03-22",
"role": "Membre du Conseil d\u0027administration"
},
"object": null,
"subject": "e6",
"_value_raw": {
"date": "22/03/2013",
"role": "Membre du Conseil d\u0027administration"
}
},
{
"date": "2013-03-22",
"type": "officer_resignation",
"quote": "D\u00E9mission de: 2. Ferring S.A.",
"value": {
"date": "2013-03-22",
"role": "Membre du Conseil d\u0027administration"
},
"object": null,
"subject": "e7",
"_value_raw": {
"date": "22/03/2013",
"role": "Membre du Conseil d\u0027administration"
}
},
{
"type": "filing_representative",
"quote": "Leo Neels Directeur g\u00E9n\u00E9ral charg\u00E9 de la gestion journali\u00E8re",
"value": {
"role": "Directeur g\u00E9n\u00E9ral charg\u00E9 de la gestion journali\u00E8re"
},
"object": null,
"subject": "e8"
}
],
"act_meta": {
"outcome": "corrected",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 1656,
"truncated": false,
"completeness_doubt": [
"Main company identity: Name \u0027Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament\u0027 (AGIM), KBO \u00270407.622.902\u0027, Legal form \u0027Association sans But Lucratif\u0027, Seat \u0027chauss\u00E9e de La Hulpe 166, 1170 BRUXELLES\u0027"
]
},
"entities": [
{
"id": "e1",
"kbo": "0400.165.679",
"kind": "company",
"name": "AstraZeneca S.A.",
"attrs": {
"seat": "rue Egide Van Ophem 110, 1180 Bruxelles"
}
},
{
"id": "e2",
"kbo": "0407.326.754",
"kind": "company",
"name": "Kela Pharma S.A.",
"attrs": {
"seat": "Industriepark West 68, 9100 Sint-Niklaas"
}
},
{
"id": "e3",
"kbo": "0861.155.805",
"kind": "company",
"name": "Baxter Belgium S.A.",
"attrs": {
"seat": "Parc de l\u0027Alliance, Boulevard d\u0027Angleterre 2-4, 1420 Braine-L\u0027Alleud"
}
},
{
"id": "e4",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD Belgium SPRL",
"attrs": {
"seat": "Clos du Lynx 5, 1200 Bruxelles"
}
},
{
"id": "e5",
"kbo": "0403.096.168",
"kind": "company",
"name": "UCB Pharma S.A.",
"attrs": {
"seat": "All\u00E9e de la Recherche 60, 1070 Bruxelles"
}
},
{
"id": "e6",
"kbo": "0400.948.213",
"kind": "company",
"name": "Bayer Healthcare S.A.",
"attrs": {
"seat": "J.E. Mommaertslaan 14, 1831 Diegem"
}
},
{
"id": "e7",
"kbo": "0428.038.135",
"kind": "company",
"name": "Ferring S.A.",
"attrs": {
"seat": "Capucienenlaan 93C, 9300 Aalst"
}
},
{
"id": "e8",
"kbo": null,
"kind": "person",
"name": "Leo Neels",
"attrs": {}
}
]
}| Legal nameNL | Ceres Pharmaceuticals |